Brief: Abbvie To Acquire Cerevel Therapeutics In Transformative Transaction To Strengthen Neuroscience Pipeline

Cerevel Therapeutics Holdings

06/12/2023 21:33

Dec 6 (Reuters) - Abbvie Inc  ABBV.N :
    * ABBVIE TO ACQUIRE CEREVEL THERAPEUTICS IN TRANSFORMATIVE
TRANSACTION TO STRENGTHEN NEUROSCIENCE PIPELINE
    * ABBVIE TO ACQUIRE CEREVEL THERAPEUTICS IN TRANSFORMATIVE
TRANSACTION TO STRENGTHEN NEUROSCIENCE PIPELINE
    * ABBVIE INC - TRANSACTION VALUED AT $45.00 PER SHARE IN
CASH, FOR
A TOTAL EQUITY VALUE OF APPROXIMATELY $8.7 BILLION
    * ABBVIE INC: TRANSACTION VALUED AT $45.00 PER SHARE IN
CASH, FOR
A TOTAL EQUITY VALUE OF APPROXIMATELY $8.7 BILLION
    * ABBVIE INC - BOARDS OF DIRECTORS OF BOTH COMPANIES HAVE
APPROVED
TRANSACTION
    * ABBVIE INC - BOARDS OF DIRECTORS OF BOTH COMPANIES HAVE
APPROVED
TRANSACTION
    * ABBVIE INC - TRANSACTION IS EXPECTED TO CLOSE IN MIDDLE OF
2024
    * ABBVIE INC - PROPOSED TRANSACTION IS EXPECTED TO BE
ACCRETIVE TO
ADJUSTED DILUTED EARNINGS PER SHARE (EPS) BEGINNING IN 2030

Source text for Eikon:  ID:nPn9pRz7Ja 
Further company coverage:  ABBV.N 

 ((Reuters.Briefs@thomsonreuters.com;))